Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-02-02

Clinical Trial Update: Safety Tolerability DDI Short Course Treatment of LTBI Infection With High-dose Rifapentine and Isoniazid or Standard Isoniazid Preventive Therapy in HIV+ Patients (DOLPHIN & DOLPHIN TOO) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update on safety and tolerability of high-dose rifapentine with isoniazid for latent TB infection in HIV+ patients, compared to standard INH the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Isoniazid preventive therapy (standard dose) (isoniazid)
  • Rifapentine + isoniazid high-dose regimen (rifapentine; isoniazid)

Snippet

Sponsor: The Aurum Institute NPC | Conditions: Respiratory Tract Infections, HIV Infections | Phase 1, Phase 2 | Status: COMPLETED